Development and validation of an LC-MS/MS method for the quantitative determination of aripiprazole and its main metabolite, OPC-14857, in human plasma
スポンサーリンク
概要
- 論文の詳細を見る
- 2005-08-05
著者
-
KUBO Masanori
Clinical Pharmacology, Department of Clinical Research and Development Otsuka Pharmaceutical Co., Lt
-
Osumi Takahiko
Department Of Drug Metabolism Drug Safety Research Center Tokushima Research Institute Otsuka Pharma
-
Hirao Yukihiro
Department Of Drug Metabolism Drug Safety Research Center Tokushima Research Institute Otsuka Pharma
-
MIZOOKU Yasuo
Pharmaceutical Business Division, Pharmaceutical Analysis Laboratory, Sumika Chemicals Analysis Serv
-
Kubo Masanori
Clinical Pharmacology Department Of Clinical Research & Development Otsuka Pharmaceutical Co. Lt
-
Mizooku Yasuo
Pharmaceutical Business Division Pharmaceutical Analysis Laboratory Sumika Chemicals Analysis Servic
関連論文
- The relationship between the pharmacokinetics of a new antipsychotic, aripiprazole, and CYP2D6 genetic polymorphism in healthy adult volunteers
- Development and validation of an LC-MS/MS method for the quantitative determination of aripiprazole and its main metabolite, OPC-14857, in human plasma